Table 1. Background of individuals with LS.
| Background | Values |
|---|---|
| Individuals | 92 |
| Male/female | 42/50 |
| Germline variant | |
| MLH1 [obligation carrier] | 75 [20] |
| MSH2 | 16 |
| MSH6 | 1 |
| Age at the last follow-up, years | 56 (23–90) |
| Individuals who developed any cancer | 70 (76%) |
| Age at initial cancer, years | 44 (17–78) |
| Origin of initial cancer | |
| Colorectum | 43 |
| Endometrium | 14 |
| Gastric | 5 |
| Ovary | 4 |
| Biliary tract | 2 |
| Small intestine | 1 |
| Brain | 1 |
| Individuals who developed BTC | 6 |
| Age at initial BTC, years | 69 (34–78) |
Data are presented as number, median (range) or n (percentage). LS, Lynch syndrome; BTC, biliary tract cancer.